Does DOCETAXEL Cause Second primary malignancy? 205 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 205 reports of Second primary malignancy have been filed in association with DOCETAXEL (Docetaxel). This represents 0.3% of all adverse event reports for DOCETAXEL.
205
Reports of Second primary malignancy with DOCETAXEL
0.3%
of all DOCETAXEL reports
78
Deaths
54
Hospitalizations
How Dangerous Is Second primary malignancy From DOCETAXEL?
Of the 205 reports, 78 (38.0%) resulted in death, 54 (26.3%) required hospitalization, and 27 (13.2%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOCETAXEL. However, 205 reports have been filed with the FAERS database.
What Other Side Effects Does DOCETAXEL Cause?
Alopecia (29,347)
Emotional distress (8,373)
Anxiety (7,379)
Psychological trauma (6,981)
Madarosis (6,883)
Hair texture abnormal (6,204)
Hair colour changes (6,078)
Hair disorder (5,652)
Pain (5,414)
Diarrhoea (4,115)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which DOCETAXEL Alternatives Have Lower Second primary malignancy Risk?
DOCETAXEL vs DOCETAXEL ANHYDROUS
DOCETAXEL vs DOCETAXEL\DOCETAXEL ANHYDROUS
DOCETAXEL vs DOCONEXENT
DOCETAXEL vs DOCONEXENT\ICOSAPENT
DOCETAXEL vs DOCONEXENT\ICOSAPENT\PHOSPHATIDYL SERINE